The expression of IRF4 and PD-1 was positively correlated, and the overexpression of IRF4 was found to impede the proliferation and migration of HCC by suppressing the JAK2/STAT3 signaling pathway and epithelial-mesenchymal transition [48]. Here, JAK2 is linked to hepatocellular carcinoma.